Kiromic Biopharma, Inc. Quarterly Return On Assets in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Kiromic Biopharma, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2021 to Q3 2024.
  • Kiromic Biopharma, Inc. Return On Assets for the quarter ending September 30, 2024 was -211 %, a 19.9% decline year-over-year.
  • Kiromic Biopharma, Inc. annual Return On Assets for 2023 was -158 %, a 20.1% increase from 2022.
  • Kiromic Biopharma, Inc. annual Return On Assets for 2022 was -197 %, a 66.3% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -211 -35.1 -19.9% Jul 1, 2024 Sep 30, 2024
Q2 2024 -170 +69.9 +29.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 -166 +61.2 +27% Jan 1, 2024 Mar 31, 2024
Q4 2023 -158 +39.7 +20.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -176 -4.4 -2.56% Jul 1, 2023 Sep 30, 2023
Q2 2023 -240 -126 -112% Apr 1, 2023 Jun 30, 2023
Q1 2023 -227 -113 -98.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -197 -78.7 -66.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -172 -63.5 -58.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -113 +68.5 +37.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -114 Jan 1, 2022 Mar 31, 2022
Q4 2021 -119 Oct 1, 2021 Dec 31, 2021
Q3 2021 -108 Jul 1, 2021 Sep 30, 2021
Q2 2021 -182 Apr 1, 2021 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.